From Name

From Email

To Name

To Email

Message

Nasal Spray Is a New Antidepressant Option for People at High Risk of Suicide

from <i>NPR</i>

Nasal Spray Is a New Antidepressant Option for People at High Risk of Suicide NPR The Food and Drug Administration has approved a variant of the anesthetic and party drug ketamine for suicidal patients with major depression. The drug is a nasal spray called Spravato and it contains esketamine, a chemical cousin of ketamine. In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn't responded to other treatments. READ MORE

more